What Company Owns Velcade? Understanding the Takeda and Janssen Partnership
•
4 min read
Originally co-developed by Millennium Pharmaceuticals and Janssen, the ownership and commercialization rights of the cancer drug Velcade are now split between two major pharmaceutical players. Takeda Pharmaceuticals, which acquired Millennium in 2008, handles the United States market, while Janssen Pharmaceutical Companies of Johnson & Johnson manage sales and distribution in Europe and most other parts of the world.
